Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
Clinical trial NCT01259102 · COMPLETED
Trial details
- NCT number
- NCT01259102
- Sponsor
- Purdue Pharma LP
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
- Primary completion
- 2001-03-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.